204 results on '"Mir, Marisa"'
Search Results
2. Evolución de las causas de pérdida del injerto en trasplante renal durante 40 años (1979-2019)
3. Luminex screening first vs. direct single antigen bead assays: Different strategies for HLA antibody monitoring after kidney transplantation
4. Usefulness of the KDPI in Spain: A comparison with donor age and definition of standard/expanded criteria donor
5. Factors associated with the compensation of renal function after nephrectomy of a kidney donor
6. Factores asociados a la compensación de la función renal tras la nefrectomía para donación
7. Impact of persistent and cleared preformed HLA DSA on kidney transplant outcomes
8. MDRD or CKD-EPI for glomerular filtration rate estimation in living kidney donors
9. MDRD o CKD-EPI en la estimación del filtrado glomerular del donante renal vivo
10. Renal graft survival according to Banff 2013 classification in indication biopsies
11. Supervivencia del injerto renal según la categoría de Banff 2013 en biopsia por indicación
12. Mineral metabolism disorders, vertebral fractures and aortic calcifications in stable kidney transplant recipients: The role of gender (EMITRAL study)
13. Impact of preformed and de novo anti-HLA DP antibodies in renal allograft survival
14. Peripheral blood lymphocyte subsets change after steroid withdrawal in renal allograft recipients: a prospective study
15. Detection of HLA Donor-Specific Antibodies with Screening and/or Specificity Kits and Antibody-Mediated Rejection in Kidney Transplant Recipients
16. KDPI Score: A Comparison with Classical ECD/SCD Classification in Predicting Outcomes
17. Impact of Delayed Graft Function without Dialysis Needed
18. Steroid withdrawal Promotes B Lymphocyte Phenotypes of Operational Tolerance Predisposition in Renal Allograft Recipients
19. Different Effects on Transitional B Lymphocytes after Conversion to mTOR Inhibitors or Steroid Withdrawal in Renal Transplant Recipients
20. Antibody-Mediated Rejection With and Without HLA Donor-Specific Antibodies in Kidney-Transplantation
21. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: Does C1q-fixation matter?
22. Chronic renal allograft injury: early detection, accurate diagnosis and management
23. COVID-19 in elderly kidney transplant recipients
24. MO985EFFICACY AND SAFETY OF FERRIC CARBOXYMALTOSE IN THE MANAGEMENT OF EARLY POST-RENAL TRANSPLANT ANEMIA
25. MO954DONOR TYPE INFLUENCE IN EARLY POST KIDNEY TRASPLANTATION HYPERTRANSAMINASEMIA
26. Paternal safety of the use of mycophenolic acid in kidney transplant recipients. Results of the EMVARON study
27. SERUM ANGIOTENSIN CONVERTING ENZYME (ACE)-2 ACTIVITY AS A MARKER OF GRAFT FUNCTION IN KIDNEY TRANSPLANT (KT) PATIENTS: RO-128
28. A HIGHER DECREASE IN TACROLIMUS TROUGH BLOOD LEVELS FOLLOWING TWICE-DAILY TO ONCE-DAILY TACROLIMUS CONVERSION OCCURS IN STEROID FREE RENAL ALLOGRAFT RECIPIENTS: O-303
29. RENAL PATIENTS SHOWED A POOR RESPONSE TO THE 2009 PANDEMIC NEW INFLUENZA A H1N1 VIRUS VACCINE: O-152
30. Kidney transplantation outcomes from elderly donors after circulatory death: a comparison with elderly brain-dead donors
31. Clinical Profiles in Renal Patients with COVID-19
32. Relevance of KDPI value and acute rejection on kidney transplant outcomes in recipients with delayed graft function – a retrospective study
33. MO013PATERNAL SAFETY OF THE USE OF MYCOPHENOLIC ACID BY KIDNEY TRANSPLANT RECIPIENTS. RESULTS OF THE EMVARON STUDY
34. Poster Board #-Session: P96-I In the Novo Kidney Transplant Recipients Higher Dosis of Advagraf® Compared to Prograf® Are Needed To Get Therapeutic Levels.: Abstract# 753
35. Hypopituitarism associated with mycotic aneurysm of the cavernous carotid artery in a renal transplant recipient
36. Circulating Endothelial Progenitor Cells After Kidney Transplantation
37. Transplantation: basic immunology meets clinical practise: TO12 CONCENTRATION AND PROLIFERATION OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS ARE IMPAIRED IN KIDNEY TRANSPLANTED PATIENTS
38. SUCCESSFUL OUTCOME OF POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS IN KIDNEY TRANSPLANT RECIPIENTS
39. Stroke in renal transplant recipients: epidemiology, predictive risk factors and outcome
40. Case report: Can a patient with an active cancer receive a kidney transplant?
41. FO037HLA ANTIBODY IMMUNIZATION: PREGNANCY AS A NATURAL SOURCE
42. SP779DIFFERENT EFFECTS ON TRANSITIONAL B LYMPHOCYTES AFTER CONVERSION TO mTOR INHIBITORS OR STEROID WITHDRAWAL IN RENAL TRANSPLANT RECIPIENTS
43. SP713MEMBRANE ATTACK COMPLEX AS A NEW TOOL TO EVALUATE COMPLEMENT ACTIVATION IN KIDNEY TRANSPLANT RECIPIENTS WITH DONOR-SPECIFIC ANTIBODIES
44. SP775PERIPHERAL LYMPHOCYTE CHANGES IN RENAL ALLOGRAFT RECIPIENTS AFTER CONVERSION TO mTOR INHIBITORS
45. FP764FRAILTY AMONG PATIENTS ON THE KIDNEY TRANSPLANT WAITING LIST AND ITS RELATION WITH DEPENDENCY AND DEPRESSION
46. SP708Different strategies to assess HLA antibodies after kidney tranplantation: Luminex screening vs. Single antigen bead assays
47. FP799KIDNEY TRANSPLANTATION FROM ELDERLY DONORS AFTER CONTROLLED CIRCULATORY DEATH HAVE SIMILAR OUTCOMES COMPARED TO THOSE FROM ELDERLY DECEASED DONORS
48. Gender differences in cancer risk after kidney transplantation
49. Kidney transplantation outcomes from elderly donors after circulatory death: a comparison with elderly brain-dead donors.
50. Fe de errores de 'Supervivencia del injerto renal según la categoríade Banff 2013 en biopsia por indicación'
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.